Status:
COMPLETED
Correlating In Vitro Fertilization Outcomes After Euploid Blastocyst Transfer With Sperm DNA Fragmentation
Lead Sponsor:
Reproductive Medicine Associates of New Jersey
Conditions:
Male Infertility
Eligibility:
All Genders
35-40 years
Brief Summary
The purpose of this study is to determine if sperm DNA fragmentation is associated with in vitro fertilization (IVF) outcomes when euploid embryos are transferred.
Detailed Description
The purpose of this study is to determine if sperm DNA fragmentation is associated with in vitro fertilization (IVF) outcomes when euploid embryos are transferred. Euploid embryos are those that have ...
Eligibility Criteria
Inclusion
- Completing first IVF/ICSI cycle at Reproductive Medicine Associates of New Jersey
- Couple undergoing CCS (Comprehensive Chromosome Screening)
- Female age 35-40 years
- Male will have to refrain from ejaculation no less than 2 days but no greater than 5 days prior semen specimen production on day of oocyte retrieval
Exclusion
- Known genetic abnormality
- Use of sperm donation or cryopreserved sperm
- Use of Oocyte donation
- Use of gestational carrier
- Use of testicular aspiration or biopsy procedures to obtain sperm
- Presence of varicosele
- Presence of hydrosalpinges that communicate with endometrial cavity
- Any contradictions to undergoing in vitro fertilization or gonadotropin stimulation
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2018
Estimated Enrollment :
323 Patients enrolled
Trial Details
Trial ID
NCT02268123
Start Date
October 1 2014
End Date
July 1 2018
Last Update
September 11 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Reproductive Medicine Associates of New Jersey
Basking Ridge, New Jersey, United States, 07920
2
Reproductive Medicine Associates of Pennsylvania at LeHigh Valley
Allentown, Pennsylvania, United States, 18104